Simeprevir

Chemical formula: C₃₈H₄₇N₅O₇S₂  Molecular mass: 749.939 g/mol  PubChem compound: 24873435

Active ingredient description

Simeprevir is a specific inhibitor of the hepatitis C virus (HCV) NS3/4A serine protease, which is essential for viral replication. In a biochemical assay, simeprevir inhibited the proteolytic activity of recombinant genotype 1a and 1b HCV NS3/4A proteases, with median Ki values of 0.5 nM and 1.4 nM, respectively.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J05AP05 J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP05

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 923604-59-5
DrugBank Drug: DB06290
KEGG Drug: D10081
PubChem Compound: 24873435
RxNorm Ingredient: 1482790
SNOMED-CT Concept: 708823009
Simeprevir (substance)
UNII Identifier: 9WS5RD66HZ
SIMEPREVIR

Medicines

Simeprevir is an active ingredient of these brands:

Brazil (BR)

Estonia (EE)

Lithuania (LT)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.